MedPath

BUTORPHANOL NASAL SPRAY

BUTORPHANOL NASAL SPRAY

Approved
DIN Number

02242504

Drug Class

Human

Market Date

Aug 1, 2000

Company
HC

aa pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242504
AIG Number0112394002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
N02AF01 BUTORPHANOL
Product Specifications
Dosage FormSolution
Route of AdministrationNasal
AHFS Classification28:08.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

BUTORPHANOL TARTRATEActive
Strength: 10 MG / ML
Monograph: BUTORPHANOL TARTRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.